CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
89 hedge funds and large institutions have $133M invested in Concert Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 23 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
Holders
89
Holding in Top 10
1
Calls
$110K
Puts
–
Top Buyers
| 1 | +$5.54M | |
| 2 | +$1.79M | |
| 3 | +$1.19M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.17M |
| 5 |
Renaissance Technologies
New York
|
+$1.16M |
Top Sellers
| 1 | -$4.19M | |
| 2 | -$2.19M | |
| 3 | -$1.81M | |
| 4 |
SAM
Senzar Asset Management
New York
|
-$1.77M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$1.69M |